用户名:
密 码:
注册
|
忘记密码?
首 页
药品信息
药品检索
全部药品
适应症分类
热门药品
专利信息
专利检索
专利权人导航
专利权人分组导航
分类查询
IPC导航
热门检索
专利分析
概况
申请趋势分析
申请人分析
发明人分析
IPC分析
项目文档
项目
个人项目
文档
个人文档
企业文档
公共文档
标签
互动
特色功能
广州科技订制咨询
特色资讯
医药新闻
帮助中心
关于本软件
药品
文档
专利
新闻
所有专利
选择导航
专利权人导航
专利权人分组导航
分类导航
分类导航
药物制剂专利
塞剂,栓剂
软膏
溶液
乳剂,分散液
多重乳剂
气雾剂
脂质体
单层囊
粉末剂、散剂
颗粒剂,微球
吸附物
冻干粉针
片剂、丸剂、锭剂
缓释剂
包衣剂
印花、压纹、开槽或打孔片
泡腾剂
胶囊
微胶囊
缓释胶囊
药物用途专利
消化道系统药物专利
代谢类疾病药物专利
减肥药专利
降血脂药专利
降糖药专利
胰岛素类降糖药专利
平衡电解质药物专利
内分泌系统药物专利
血液系统药物专利
抗血栓药物专利
抗出血药物专利
心脑血管系统药物专利
抗高血压药物专利
呼吸系统药物专利
泌尿系统药物专利
生殖系统药物专利
皮肤疾病药物专利
骨骼疾病药物专利
神经系统药物专利
中枢作用止痛药物专利
抗偏头痛药物专利
抗癫痫药物专利
抗精神病药物专利
镇静安眠药物专利
抗焦虑、抑郁药物专利
神经兴奋药物专利
抗老年痴呆药物专利
眼科、耳科药物专利
止疼、退热、消炎药物专利
抗感染药物专利
局部抗菌药物专利
抗菌药物专利
抗真菌药物专利
抗病毒药物专利
抗肿瘤药物专利
抗过敏、免疫系统药物专利
免疫调节药物专利
免疫兴奋剂专利
免疫抑制剂专利
抗过敏药物专利
专利信息
Translation Company
查询条件
展开筛选条件
[IPC] 包含 'a61k0009133'
清空条件
查询
分析
排序
公开日
公开号
申请日
申请号
中文标题
英文标题
降序
升序
翻到页码
标题
标题2
专利权人
发明人
附图
摘要
摘要2
优先权号
IPC
专利类型
首页
1
2
3
4
下页
尾页
共
32
条记录, 当前第1/4页。
公开号
公开日
申请号
申请日
1.
EP2501364A1
2012/9/26
EP20100831847
2010/11/15
专利标题
:PARENTERAL FORMULATIONS OF GEMCITABINE DERIVATIVES
专利权人
:
CLAVIS PHARMA ASA [NO]
;
2.
KR20120086729A
2012/8/3
KR20127015947
2010/11/15
专利标题
:PARENTERAL FORMULATIONS OF GEMCITABINE DERIVATIVES
专利权人
:
CLAVIS PHARMA ASA [NO]
;
3.
KR20120084900A
2012/7/31
KR20110006211
2011/1/21
专利标题
:PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF CANCER COMPRISING OUTER MEMBRANE VESICLES AS AN ACTIVE INGREDIENT
专利权人
:
INST SCIENCE & TECH KWANGJU [KR]
;
PURPOSE: A pharmaceutical composition containing outer membrane vesicles for anticancer is provided to effectively deliver an anticancer agent into cells and enable cancer treatment of high specificity. CONSTITUTION: An outer membrane vesicles(OMVs) for anti-cancer comprises: an outer membrane proteins(OMPs), a cancer-targeting ligand conjugated to the outer membrane vesicles
4.
AU2010322516A1
2012/5/17
AU20100322516
2010/11/15
专利标题
:Parenteral formulations of gemcitabine derivatives
专利权人
:
CLAVIS PHARMA AS
;
The present invention relates to parenteral formulations for certain long chain saturated and monounsaturated fatty acid derivatives of 2',2'-difluorodeoxycytidine (Gemcitabine). In particular, the present invention relates to a parenteral pharmaceutical composition and a method of the preparation thereof, in order to accommodate therapeutically effective doses of the said derivatives ameliorating compliance in the treatment of cancer. The composition has an average particle size in the range of...
5.
WO2011062503A1
2011/5/26
WO2010NO00417
2010/11/15
专利标题
:PARENTERAL FORMULATIONS OF GEMCITABINE DERIVATIVES
专利权人
:
CLAVIS PHARMA AS [NO]
;
AHRABI SAYEH [NO]
;
MYHREN FINN [NO]
;
ERIKSEN OLE HENRIK [NO]
;
The present invention relates to parenteral formulations for certain long chain saturated and monounsaturated fatty acid derivatives of 2',2'-difluorodeoxycytidine (Gemcitabine). In particular, the present invention relates to a parenteral pharmaceutical composition and a method of the preparation thereof, in order to accommodate therapeutically effective doses of the said derivatives ameliorating compliance in the treatment of cancer. The composition has an average particle size in the range of...
6.
EP2253308A1
2010/11/24
EP20090160913
2009/5/22
专利标题
:Pharmaceutical composition comprising microbubbles for targeted tumor therapy
专利权人
:
UNIV MUENCHEN L MAXIMILIANS [DE]
;
UNIV RUPRECHT KARLS HEIDELBERG [DE]
;
The present invention relates to a pharmaceutical composition for the targeted delivery of a pharmaceutically active compound, the composition comprising soft, gas-filled particles having an envelope monolayer comprising one or more surfactants and a pharmaceutically active compound. More particularly, the invention relates to a pharmaceutical composition, wherein the envelope monolayer of the gas-filled particles have a negative overall net charge, and wherein the pharmaceutically active compou...
7.
NZ546439A
2010/4/30
NZ20040546439
2004/11/3
专利标题
:Method for preparing submicron particles of paclitaxel
专利权人
:
BAXTER INT
;
Disclosed is a method for preparing a pharmaceutical composition of submicron particles of precipitated paclitaxel or its derivative compounds, the solubility of which is greater in a water miscible first solvent than in a second solvent that is aqueous, the method comprising the steps of: (i) mixing into the water-miscible first solvent or the second solvent or both the water miscible first solvent and the second solvent, a first surface modifier comprising a phospholipid conjugated with a wate...
8.
WO2009009115A2
2009/1/15
WO2008US08501
2008/7/11
专利标题
:LIPOSOME COMPOSITIONS FOR TREATMENT OF HEPATITIS C
专利权人
:
NEVSKY PHARMACEUTICAL DEV [US]
;
YUZHAKOV ALEXANDER [US]
;
In the present invention compositions and methods are described for treating patients with a hepatitis C viral infection typically using interferon-alpha and/or ribavirin which are incorporated into liposomes, wherein the liposomes typically contain at least one carbohydrate moiety on the surface, such as a mono-, di-, oligo-, or polysaccharide moiety or any combination thereof, for targeting to hepatocytes. Other liposome surface modifications are provided to enhance effectiveness of the compou...
9.
US2009017108A1
2009/1/15
US20080216830
2008/7/11
专利标题
:Liposome compositions for treatment of hepatitis C
专利权人
:
In the present invention compositions and methods are described for treating patients with a hepatitis C viral infection typically using interferon-alpha and/or ribavirin which are incorporated into liposomes, wherein the liposomes typically contain at least one carbohydrate moiety on the surface, such as a mono-, di-, oligo-, or polysaccharide moiety or any combination thereof, for targeting to hepatocytes. Other liposome surface modifications are provided to enhance effectiveness of the compou...
10.
NZ540778A
2008/4/30
NZ20030540778
2003/12/31
专利标题
:Non-pegylated long-circulating liposomes
专利权人
:
ZYDUS BSV RES AND DEV PRIVATE
;
Along circulating non-pegylated liposomal doxorubicin composition for parenteral administration and a process for its preparation. The circulation time in swiss albino mice is at least 25 times longer than conventional non-liposomal compositions. The non-pegylated liposomes are stable, exhibit low toxicity and have been found to be efficacious in different tumor models.
首页
1
2
3
4
下页
尾页
共
32
条记录, 当前第1/4页。
当前查询条件: [IPC] 包含 'a61k0009133'
查询范围
在当前结果中查询
!
专利类型
发明
实用新型
外观设计
!
公开号
CN1234
!
申请号
CN1234
!
专利标题
扩展
PHARMA
!
专利权人
扩展
pfizer
发明人
!
申请日
yyyymmdd
!
公开日
yyyymmdd
优先权号
!
摘要
扩展
PHARMA
IPC
A01B
下载范围
下载第
到
条记录。
下载内容
题录信息
专利全文